Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Androgenetic alopecia treatments focus on reducing hair loss by targeting hormones, with new therapies showing promise but needing more research.

PCOS is a common hormonal disorder in women that causes various symptoms and health risks, requiring personalized treatment.

Surgical removal of an adrenal tumor resolved hormonal issues in a young woman.

A 22-year-old woman with a rare genetic condition was successfully treated to develop normal female characteristics and regular menstruation.

Androgen receptor degrader drugs may be a promising future treatment for hair loss.

Hormones, especially testosterone and DHT, are key for penis development and function, and testosterone therapy may help with erectile dysfunction in those with low levels.

Aging causes sweat glands to shrink, leading to skin issues, and blue light can help hair grow.

The document concludes that hair loss in women can be treated with topical treatments or hormone therapy depending on the cause.

Early diagnosis and treatment are crucial for complex medical conditions.

Platelet-rich plasma injections are a promising new treatment for hair loss, showing initial positive results.

The mouse model could be useful for baldness research and testing treatments like testosterone, cyproterone acetate, and minoxidil.

CAH requires a multidisciplinary approach, and while current treatments help, future therapies show promise.

Early diagnosis and lifestyle changes are crucial for managing PCOD.

Minoxidil and finasteride are the main FDA-approved treatments for hair loss, with other methods showing promise but lacking strong evidence.

Treating hair loss in PCOS involves a combination of lifestyle changes, medication, and possibly hair care strategies.

Spironolactone is an effective and well-tolerated first-line treatment for hidradenitis suppurativa in women.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

The conclusion is that proper diagnosis and long-term treatment, including medication, hair removal, and lifestyle changes, are important for improving hirsutism, especially in PCOS patients.

New treatments for hair loss include low-dose oral minoxidil, light therapy, and innovative therapies targeting hair growth mechanisms.

Environmental, chemical, mechanical, and personal health factors can all damage hair and contribute to hair loss or changes in hair quality.

Flutamide, an oral anti-androgen therapy, is effective in treating female pattern hair loss, even without systemic androgen excess.

Hidradenitis suppurativa improves with antiandrogen therapy.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

Menopause can cause hair loss in women due to hormonal changes, affecting their well-being and quality of life.

Female pattern hair loss is common in women with polycystic ovarian syndrome.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.